Meta-analysisindependent cross-checkabstract checked★ key study I-VEG-01 in-depth review

Fibre and health (Lancet 2019)

Carbohydrate quality and human health: a series of systematic reviews and meta-analyses.

Overview

Reynolds A et al.. Lancet 2019 · PMID 30638909 · DOI 10.1016/S0140-6736(18)31809-9

High fibre intake is linked to 15-30% lower death and disease rates; trials show better weight, blood pressure and cholesterol.

Does the study support the specific claim? No · Methodological quality: high

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Fibre and NCDs

How was the study done?

Meta-analyses

How many people, animals or samples were studied?

185 cohorts, 58 RCTs

What was actually found?

Large benefits

How large was the observed effect?

15-30% lower risk

What do the results mean in everyday life?

Eat 25-29 g fibre daily.

What are the study's limitations?

Observational endpoints

What does it say about Elawady's specific claim?

Contradicts 'cattle food'

Do the results apply to Germany and Europe?

High

What can explicitly not be concluded from this study?

Not specific to leafy greens.

Scientific in-depth review

1. Full reference

Authors
Reynolds A et al.
Journal
Lancet
Year
2019
Identifier
PMID 30638909 DOI 10.1016/S0140-6736(18)31809-9
Verification
verified – PubMed efetch 2026-10-25
Retracted
no
Corrections

Erratum published (Lancet 2019;393:406)

Extent checked
abstract only
Conflicts of interest and funding

Health Research Council of New Zealand, WHO and others

2. Research question

Carbohydrate quality markers (fibre, whole grains, GI) and NCD outcomes.

3. Study design and population

Study design
Meta-analysis – Series of systematic reviews and meta-analyses of prospective studies and RCTs (GRADE)
Population

Adults without chronic disease

Country

Multiple

Period

Cohorts to April 2017; RCTs to Feb 2018

Sample size

185 prospective studies (~135 million person-years); 58 RCTs (4,635 adults)

Inclusion and exclusion criteria

Excluded chronic disease, weight-loss and supplement trials

4. Methods and endpoints

Exposure / intervention

Higher dietary fibre

Comparator

Lower fibre

Endpoints

Mortality, CHD, stroke, T2D, colorectal cancer; risk factors

Statistical methods

Random effects; dose-response; GRADE

5. Actual results

Results

Highest vs lowest fibre: 15-30% decrease in all-cause and CV mortality, CHD, stroke, T2D, colorectal cancer; RCTs: lower body weight, systolic BP, total cholesterol; greatest risk reduction at 25-29 g/day; certainty moderate for fibre.

Absolute risks

not reported

Authors' conclusion

Relationships could be causal; increasing fibre expected to benefit health.

6. Strengths

  • Large
  • Cohorts + RCTs
  • GRADE

7. Weaknesses

  • Observational for hard endpoints

8. Risk of bias

Orienting tool
AMSTAR 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
low
Rationale

High-quality review series.

9. Assessment of the statistical interpretation

Consistent dose-response.

10. Relevance to the specific claim

Contradicts the claim that non-digestible plant material is harmful.

11. Independent contrary findings

None.

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Key evidence.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualityhigh
Risk of biaslow
Precision of resultshigh
Directnessindirect
Reproducibilityreplicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Fibre source-specific effects.

15. Linked fact checks